1. Home
  2. QTTB vs WVVI Comparison

QTTB vs WVVI Comparison

Compare QTTB & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • WVVI
  • Stock Information
  • Founded
  • QTTB 2015
  • WVVI 1983
  • Country
  • QTTB United States
  • WVVI United States
  • Employees
  • QTTB N/A
  • WVVI N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • WVVI Beverages (Production/Distribution)
  • Sector
  • QTTB Health Care
  • WVVI Consumer Staples
  • Exchange
  • QTTB Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • QTTB 23.3M
  • WVVI 20.4M
  • IPO Year
  • QTTB N/A
  • WVVI N/A
  • Fundamental
  • Price
  • QTTB $2.27
  • WVVI $2.82
  • Analyst Decision
  • QTTB Hold
  • WVVI
  • Analyst Count
  • QTTB 7
  • WVVI 0
  • Target Price
  • QTTB $12.17
  • WVVI N/A
  • AVG Volume (30 Days)
  • QTTB 214.3K
  • WVVI 15.7K
  • Earning Date
  • QTTB 11-07-2025
  • WVVI 11-13-2025
  • Dividend Yield
  • QTTB N/A
  • WVVI N/A
  • EPS Growth
  • QTTB N/A
  • WVVI N/A
  • EPS
  • QTTB N/A
  • WVVI N/A
  • Revenue
  • QTTB N/A
  • WVVI $38,384,350.00
  • Revenue This Year
  • QTTB N/A
  • WVVI N/A
  • Revenue Next Year
  • QTTB N/A
  • WVVI N/A
  • P/E Ratio
  • QTTB N/A
  • WVVI N/A
  • Revenue Growth
  • QTTB N/A
  • WVVI N/A
  • 52 Week Low
  • QTTB $1.35
  • WVVI $2.49
  • 52 Week High
  • QTTB $51.26
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 40.57
  • WVVI 31.67
  • Support Level
  • QTTB $2.50
  • WVVI $2.75
  • Resistance Level
  • QTTB $2.61
  • WVVI $3.84
  • Average True Range (ATR)
  • QTTB 0.31
  • WVVI 0.26
  • MACD
  • QTTB -0.12
  • WVVI -0.07
  • Stochastic Oscillator
  • QTTB 8.28
  • WVVI 25.81

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: